Go Pro

Rapid Micro Biosystems (RPID) Competitors

Rapid Micro Biosystems logo
$2.05 +0.31 (+17.82%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$2.07 +0.02 (+0.93%)
As of 07/10/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RPID vs. MASS, PRE, SENS, NAUT, and QSI

Should you buy Rapid Micro Biosystems stock or one of its competitors? MarketBeat compares Rapid Micro Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rapid Micro Biosystems include 908 Devices (MASS), Prenetics Global (PRE), Senseonics Holdings, Inc. Common Stock (SENS), Nautilus Biotechnology (NAUT), and Quantum-Si (QSI). These companies are all part of the "measuring and control equipment" industry.

How does Rapid Micro Biosystems compare to 908 Devices?

Rapid Micro Biosystems (NASDAQ:RPID) and 908 Devices (NASDAQ:MASS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 88.1% of 908 Devices shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 28.2% of 908 Devices shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Rapid Micro Biosystems has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market. Comparatively, 908 Devices has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

In the previous week, 908 Devices had 3 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 4 mentions for 908 Devices and 1 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.87 beat 908 Devices' score of 0.68 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company Overall Sentiment
Rapid Micro Biosystems Very Positive
908 Devices Positive

908 Devices has a net margin of -62.40% compared to Rapid Micro Biosystems' net margin of -145.81%. 908 Devices' return on equity of -14.03% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.81% -131.52% -67.48%
908 Devices -62.40%-14.03%-10.40%

Rapid Micro Biosystems presently has a consensus price target of $6.00, suggesting a potential upside of 192.68%. 908 Devices has a consensus price target of $12.00, suggesting a potential upside of 48.15%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, equities analysts clearly believe Rapid Micro Biosystems is more favorable than 908 Devices.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
908 Devices
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

908 Devices has higher revenue and earnings than Rapid Micro Biosystems. 908 Devices is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$33.59M2.82-$47.12M-$1.12N/A
908 Devices$56.20M5.45$19.49M-$1.00N/A

Summary

908 Devices beats Rapid Micro Biosystems on 10 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 7.8% of Prenetics Global shares are held by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Prenetics Global had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 2 mentions for Prenetics Global and 1 mentions for Rapid Micro Biosystems. Prenetics Global's average media sentiment score of 1.89 beat Rapid Micro Biosystems' score of 1.87 indicating that Prenetics Global is being referred to more favorably in the media.

Company Overall Sentiment
Prenetics Global Very Positive
Rapid Micro Biosystems Very Positive

Prenetics Global has a beta of 0.26, indicating that its stock price is 74% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

Prenetics Global currently has a consensus target price of $31.75, suggesting a potential upside of 77.77%. Rapid Micro Biosystems has a consensus target price of $6.00, suggesting a potential upside of 192.68%. Given Rapid Micro Biosystems' higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Prenetics Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Prenetics Global has a net margin of -62.45% compared to Rapid Micro Biosystems' net margin of -145.81%. Prenetics Global's return on equity of -20.33% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-62.45% -20.33% -15.42%
Rapid Micro Biosystems -145.81%-131.52%-67.48%

Prenetics Global has higher revenue and earnings than Rapid Micro Biosystems. Prenetics Global is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39M3.26-$37.71M-$4.58N/A
Rapid Micro Biosystems$33.59M2.82-$47.12M-$1.12N/A

Summary

Prenetics Global beats Rapid Micro Biosystems on 10 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Senseonics Holdings, Inc. Common Stock?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Rapid Micro Biosystems has lower revenue, but higher earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics Holdings, Inc. Common Stock$35.26M6.38-$69.11M-$2.00N/A
Rapid Micro Biosystems$33.59M2.82-$47.12M-$1.12N/A

In the previous week, Senseonics Holdings, Inc. Common Stock and Senseonics Holdings, Inc. Common Stock both had 1 articles in the media. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.87 equaled Rapid Micro Biosystems'average media sentiment score.

Company Overall Sentiment
Senseonics Holdings, Inc. Common Stock Very Positive
Rapid Micro Biosystems Very Positive

Rapid Micro Biosystems has a net margin of -145.81% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Senseonics Holdings, Inc. Common Stock's return on equity of -129.97% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Senseonics Holdings, Inc. Common Stock-213.87% -129.97% -67.14%
Rapid Micro Biosystems -145.81%-131.52%-67.48%

Senseonics Holdings, Inc. Common Stock presently has a consensus price target of $17.00, indicating a potential upside of 215.99%. Rapid Micro Biosystems has a consensus price target of $6.00, indicating a potential upside of 192.68%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, equities research analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Rapid Micro Biosystems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Senseonics Holdings, Inc. Common Stock has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

Summary

Senseonics Holdings, Inc. Common Stock beats Rapid Micro Biosystems on 8 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Nautilus Biotechnology has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market.

In the previous week, Nautilus Biotechnology had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 2 mentions for Nautilus Biotechnology and 1 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.87 beat Nautilus Biotechnology's score of 0.93 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.

Company Overall Sentiment
Nautilus Biotechnology Positive
Rapid Micro Biosystems Very Positive

Nautilus Biotechnology has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -145.81%. Nautilus Biotechnology's return on equity of -35.04% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Nautilus BiotechnologyN/A -35.04% -29.16%
Rapid Micro Biosystems -145.81%-131.52%-67.48%

50.7% of Nautilus Biotechnology shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 41.1% of Nautilus Biotechnology shares are owned by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Rapid Micro Biosystems has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nautilus BiotechnologyN/AN/A-$59M-$0.46N/A
Rapid Micro Biosystems$33.59M2.82-$47.12M-$1.12N/A

Nautilus Biotechnology currently has a consensus target price of $4.00, suggesting a potential upside of 111.64%. Rapid Micro Biosystems has a consensus target price of $6.00, suggesting a potential upside of 192.68%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Nautilus Biotechnology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nautilus Biotechnology
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Rapid Micro Biosystems beats Nautilus Biotechnology on 9 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Quantum-Si?

Rapid Micro Biosystems (NASDAQ:RPID) and Quantum-Si (NASDAQ:QSI) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

In the previous week, Rapid Micro Biosystems and Rapid Micro Biosystems both had 1 articles in the media. Quantum-Si's average media sentiment score of 1.89 beat Rapid Micro Biosystems' score of 1.87 indicating that Quantum-Si is being referred to more favorably in the news media.

Company Overall Sentiment
Rapid Micro Biosystems Very Positive
Quantum-Si Very Positive

Rapid Micro Biosystems presently has a consensus target price of $6.00, suggesting a potential upside of 192.68%. Quantum-Si has a consensus target price of $1.00, suggesting a potential upside of 13.29%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, research analysts clearly believe Rapid Micro Biosystems is more favorable than Quantum-Si.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Quantum-Si
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Rapid Micro Biosystems has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.2, meaning that its stock price is 220% more volatile than the broader market.

Rapid Micro Biosystems has a net margin of -145.81% compared to Quantum-Si's net margin of -5,605.88%. Quantum-Si's return on equity of -47.35% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Rapid Micro Biosystems-145.81% -131.52% -67.48%
Quantum-Si -5,605.88%-47.35%-42.66%

Rapid Micro Biosystems has higher revenue and earnings than Quantum-Si. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rapid Micro Biosystems$33.59M2.82-$47.12M-$1.12N/A
Quantum-Si$2.44M78.78-$101.34M-$0.51N/A

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Quantum-Si beats Rapid Micro Biosystems on 8 of the 15 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$94.65M$7.65B$7.07B$12.66B
Dividend YieldN/A1.32%2.68%8.00%
P/E Ratio-1.8350.4327.4224.53
Price / Sales2.8245.93535.1197.70
Price / CashN/A26.5448.4760.03
Price / Book2.737.4410.886.38
Net Income-$47.12M$159.19M$3.59B$331.87M
7 Day Performance19.19%-0.26%-0.26%0.35%
1 Month Performance16.48%0.27%4.55%0.57%
1 Year Performance-38.99%4.73%29.86%22.26%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPID
Rapid Micro Biosystems
3.1213 of 5 stars
$2.05
+17.8%
$6.00
+192.7%
-39.0%$94.65M$33.59MN/A200
MASS
908 Devices
2.5715 of 5 stars
$8.07
-4.2%
$12.00
+48.7%
+16.7%$318.39M$56.20MN/A60
PRE
Prenetics Global
3.2241 of 5 stars
$16.79
-4.0%
$31.75
+89.1%
+126.4%$295.13M$92.39MN/A1
SENS
Senseonics Holdings, Inc. Common Stock
3.6888 of 5 stars
$5.33
-5.3%
$17.00
+218.9%
N/A$235.35M$35.26MN/A90
NAUT
Nautilus Biotechnology
2.3113 of 5 stars
$1.69
-1.7%
$4.00
+136.7%
+141.8%$218.58MN/AN/A130

Related Companies and Tools


This page (NASDAQ:RPID) was last updated on 7/12/2026 by MarketBeat.com Staff.
From Our Partners